Stay updated with breaking news from Prashant Tandon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nikhil Tandon and colleagues explore the impact of a quality improvement strategy for patients with type 2 diabetes 6.5 years after its implementation for the CARRS randomised trial.
Developments at Tata Digital; ride-hailing firms optimistic Our top story today is a round-up of some interesting and significant developments at Tata Digital -- specifically, its new acquisitions BigBasket and 1mg. There's a lot to get to so let's dive right in.Also in this letter:Ride-hailing firms believe the worst is behind themboAt eyes IPO in
Big-ticket investments on horizon for companies that have emerged stronger after Covid. Indian startup sector witnesses a resurgence in big-ticket deals of $100 million or more. Firms like Lenskart and Purplle are in talks for significant investments, while companies like HealthKart and Rapido negotiate fresh funding rounds.
I am writing this article to support the cautionary view expressed by Prashant Tandon (a senior journalist) who often appears on DB Live's YouTube
With this funding, Mumbai-based Neodocs aims to double down its investments in existing products, particularly focusing on its kidney care and urinary tract infections (UTI) kit. It also plans to enhance its self-diagnosis offerings by introducing a finger-prick blood test product that will provide results on a smartphone.